GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sesen Bio Inc (FRA:PCBK) » Definitions » Price-to-Funds-From-Operations

Sesen Bio (FRA:PCBK) Price-to-Funds-From-Operations : (As of Jun. 02, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sesen Bio Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Sesen Bio (FRA:PCBK) Business Description

Industry
Traded in Other Exchanges
N/A
Address
245 First Street, Suite 1800, Cambridge, MA, USA, 02142
Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG.